WASHINGTON, Jan. 8, 2018 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) (the "Company") announced that its
President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on
the Company's fourth quarter 2017 performance in a presentation at
the J.P. Morgan Healthcare Conference in San Francisco, California at 9:00 a.m. PT. Mr. Joyce will communicate that
Danaher's fourth quarter 2017 adjusted diluted net earnings per
share and core revenue growth are both expected to be above the
high-end of the Company's previously announced guidance ranges.
As previously announced, Danaher will hold its quarterly
earnings conference call for the fourth quarter and year-end 2017
on Tuesday, January 30, 2018 at
8:00 a.m. ET.
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands has leadership positions in some
of the most demanding and attractive industries, including health
care, environmental and industrial. With more than 20 operating
companies, Danaher's globally diverse team of over 62,000
associates is united by a common culture and operating system, the
Danaher Business System. For more information, please visit
www.danaher.com.
FORWARD LOOKING STATEMENTS
Statements in this
release that are not strictly historical, including the statement
regarding the Company's anticipated fourth quarter 2017 adjusted
diluted net earnings per share and core revenue growth and any
other statements regarding events or developments that we believe
or anticipate will or may occur in the future are "forward-looking"
statements within the meaning of the federal securities laws. There
are a number of important factors that could cause actual results,
developments and business decisions to differ materially from those
suggested or indicated by such forward-looking statements and you
should not place undue reliance on any such forward-looking
statements. These factors include, among other things,
deterioration of or instability in the economy, the markets we
serve and the financial markets, contractions or growth rates and
cyclicality of markets we serve, competition, our ability to
develop and successfully market new products and technologies and
expand into new markets, the potential for improper conduct by our
employees, agents or business partners, our compliance with
applicable laws and regulations (including regulations relating to
medical devices and the health care industry), our ability to
effectively address cost reductions and other changes in the health
care industry, our ability to successfully identify, consummate and
integrate appropriate acquisitions and successfully complete
divestitures and other dispositions, our ability to integrate the
recent acquisitions of Pall Corporation and Cepheid and achieve the
anticipated benefits of such transactions, contingent liabilities
relating to acquisitions and divestitures (including tax-related
and other contingent liabilities relating to the distributions of
each of Fortive Corporation and our communications business),
security breaches or other disruptions of our information
technology systems or violations of data privacy laws, the impact
of our restructuring activities on our ability to grow, risks
relating to potential impairment of goodwill and other intangible
assets, currency exchange rates, tax audits and changes in our tax
rate and income tax liabilities, changes in tax laws applicable to
multinational companies, litigation and other contingent
liabilities including intellectual property and environmental,
health and safety matters, the rights of the United States government to use, disclose
and license certain intellectual property we license if we fail to
commercialize it, risks relating to product, service or software
defects, product liability and recalls, risks relating to product
manufacturing, the impact of our debt obligations on our operations
and liquidity, our relationships with and the performance of our
channel partners, uncertainties relating to collaboration
arrangements with third parties, commodity costs and surcharges,
our ability to adjust purchases and manufacturing capacity to
reflect market conditions, reliance on sole sources of supply, the
impact of deregulation on demand for our products and services,
labor matters, international economic, political, legal, compliance
and business factors (including the impact of the UK's decision to
leave the EU), disruptions relating to man-made and natural
disasters, and pension plan costs. Additional information regarding
the factors that may cause actual results to differ materially from
these forward-looking statements is available in our SEC filings,
including our 2016 Annual Report on Form 10-K and Quarterly Report
on Form 10-Q for the third quarter of 2017. These forward-looking
statements speak only as of the date of this release and except to
the extent required by applicable law, the Company does not assume
any obligation to update or revise any forward-looking statement,
whether as a result of new information, future events and
developments or otherwise.
View original
content:http://www.prnewswire.com/news-releases/danaher-ceo-to-comment-on-financial-performance-300579538.html
SOURCE Danaher Corporation